GRIMES & Co WEALTH MANAGEMENT, LLC
Position in TGTX — Tg Therapeutics, Inc.
CIK 1321993
WESTBOROUGH, MA
Position in TGTX
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$335,134
+$132,492 QoQ
Shares Held
6,100
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#276
of 425 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GRIMES & Co WEALTH MANAGEMENT, LLC holds $18,023,555 across 11 Biotechnology names. TGTX ranks #5 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
134,448 | $15,241,025 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
53,307 | $466,702 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
2,369 | $443,665 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759 | $377,017 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
This page
|
6,100 | $335,134 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
4,011 | $326,936 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
1,287 | $315,018 | |
| 8 | INVA |
Innoviva, Inc.
|
9,722 | $220,786 |
All Filings in TGTX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $335,134 | 6,100 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $202,642 | 6,100 | Shares | Sole | 2026-04-21 | |
| 2025-09-30 | $220,362 | 6,100 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $219,539 | 6,100 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $240,523 | 6,100 | Shares | Sole | 2025-04-17 | |
| No filing history on record for this holder in this stock. | ||||||